Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-7.99	34.86	37.89
Graham Fair Price	52.42	13610.87	8929.58
PEG	-80.41	0.10	-0.50
Price/Book	-15.72	0.48	0.57
Price/Cash Flow	32.82	25.63	19.30
Prices/Earnings	-63.08	12.73	34.49
Price/Sales	-18.31	1.33	1.62
Price/FCF	32.82	25.63	19.30
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	32.11	0.15	0.11
Operating Margin	228.55	0.05	0.01
ROA	122.89	< 0.005	< 0.005
ROE	< 0.005	< 0.005	128.25
ROIC	-0.01	< 0.005	-41.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	-0.15	66.09
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.75	2.42	220.75
EPS QOQ	-0.69	1.30	88.45
FCF QOQ	-0.42	-0.36	14.06
Revenue QOQ	< 0.005	0.04	369.47
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	120.43	124.82	3.64
Days Sales Outstanding (DSO)	59.01	65.38	10.79
Inventory Turnover	0.75	0.72	-3.52
Debt/Capitalization	0.20	0.19	-5.26
Quick Ratio	0.88	0.88	-0.71
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	29399.67	29661.67	0.89
Cash	4598.46	4576.13	-0.49
Capex	-327.25	-296.33	9.45
Free Cash Flow	861.88	551.75	-35.98
Revenue	10237.88	10656.33	4.09
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.85	1.79	-3.16
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.96	6.88	-1.12
Naive Interpretation	Member

06 - Financial Health · Weak

Rating